Home | Sitemap | Contact | 中文 | CAS
Search: 
About Us
Research
Scientists
International Cooperation
News
Education & Training
Join Us
Societies & Publications
Papers
Resources
Location:Home>Research>Research Progress
 
Heavy Smoking Patients With Schizophrenia Have Less Cognitive Symptoms
 
Author: WEI Shuochi      Update time: 2022/05/17
Close
Text Size: A A A
Print

Some studies found smoking could be a form of self-medication and heavy smoking patients with schizophrenia had less clinical symptoms than non-heavy smoking patients. However, no studies have reported the relationship between heavy smoking and cognitive symptoms in Chinese patients with schizophrenia.

Prof. ZHANG Xiangyang of Institute of Psychology, Chinese Academy of Sciences has studied the cognitive symptoms between heavy smoking and non-heavy smoking patients with schizophrenia in the Chinese Han group. The results showed that heavy smoking patients with schizophrenia had less cognitive symptoms and fewer negative symptoms than non-heavy smoking patients with schizophrenia.

The study recruited 154 heavy smoking patients and 372 non-heavy smoking patients with schizophrenia. They completed a detailed questionnaire including general and socio-demographic data. The Positive and Negative Syndrome Scale (PANSS) was rated for psychopathology. The Fagerstrom Test for Nicotine Dependence (FTND) was used to assess the degree of nicotine dependence. The results showed that heavy smoking patients were younger, started smoking earlier, and had a higher FTND total score than non-heavy smoking patients. Heavy smoking patients had lower negative symptom scores and cognitive factor scores. The cognitive symptoms may be associated with the amount of smoking.

These results supported the "self-medication hypothesis". This is the first study to report the relationship between heavy smoking and cognitive symptoms in patients with schizophrenia.

The study entitled “Demographics, Clinical Characteristics and Cognitive Symptoms of Heavy Smokers and Non-heavy Smokers in Chinese Male Patients with Chronic Schizophrenia” has been published in the European Archives of Psychiatry and Clinical Neuroscience on Apr. 26, 2022. The study was supported by National Natural Science Foundation of China and International Partnership Program of Chinese Academy of Sciences.

LIU Chen
Institute of Psychology
Chinese Academy of Sciences
Beijing 100101, China.
E-mail: liuc@psych.ac.cn

16 Lincui Road, Chaoyang District, Beijing 100101, China. All Rights Reserved